You are here: Industry Insights > BioGX

News List

BioGX Announces EUA Submission of Extraction-Free Direct RT-PCR Test for COVID-19 americanpharmaceuticalreview
October 19, 2020
BioGX announced FDA Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19.
BioGX Announces EUA for Extraction-Free Direct RT-PCR Test for COVID-19 americanpharmaceuticalreview
October 16, 2020
BioGX announced U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19.
BioGX Announces FDA Emergency Use Authorization Submission of Extraction-Free Direct RT-PCR Test for COVID-19 prnasia
October 15, 2020
BioGX, a molecular diagnostics solutions company, announced FDA Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19.
BD, BioGX Announce FDA Emergency Use Authorization for COVID-19 Diagnostic Test americanpharmaceuticalreview
April 08, 2020
BD announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new diagnostic test that will enable hospitals to screen ...
BioGX Receives CE-IVD Mark For Enhanced Flu Assay En-CPhI.CN
October 24, 2019
BioGX B.V., the European subsidiary of Birmingham, Alabama based BioGX, announced it has received CE-IVD marking for its new Flu A, Flu B, RSV A/B automated test.